MCID: STT004
MIFTS: 40

Steatorrhea malady

Category: Gastrointestinal diseases

Aliases & Classifications for Steatorrhea

About this section

Aliases & Descriptions for Steatorrhea:

Name: Steatorrhea 11 27 50 39 13
 
Fatty Stool 11

Classifications:



External Ids:

Disease Ontology11 DOID:10602
MeSH39 D045602
NCIt45 C86917

Summaries for Steatorrhea

About this section
Wikipedia:71 Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult... more...

MalaCards based summary: Steatorrhea, also known as fatty stool, is related to lactose intolerance and pancreatic steatorrhea. An important gene associated with Steatorrhea is PNLIP (Pancreatic Lipase), and among its related pathways are Fat digestion and absorption and Statin Pathway. Affiliated tissues include testes, bone and pancreatic islet, and related mouse phenotype homeostasis/metabolism.

Related Diseases for Steatorrhea

About this section

Diseases related to Steatorrhea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 105)
idRelated DiseaseScoreTop Affiliating Genes
1lactose intolerance28.0APOC2, CCK, CELA1, PNLIP, SCT, SLC10A2
2pancreatic steatorrhea12.1
3celiac disease11.2
4tropical sprue11.1
5blind loop syndrome11.1
6glucose intolerance11.1
7bile acid malabsorption, primary10.9
8hypobetalipoproteinemia10.8
9hypomagnesemia 1, intestinal10.8
10pancreatitis10.4
11blue toe syndrome10.4APOC2, PNLIP
12neuronal ceroid lipofuscinosis10.4SCT, SST
13diabetes mellitus, transient neonatal, 310.3SCT, SST
14enamel erosion10.3SCT, SST
15primary progressive multiple sclerosis10.3SCT, SST
16pancreatic gastrinoma10.3SCT, SST
17migraine with aura10.3SCT, SST
18orbital cancer10.3CCK, SCT
19idiopathic bronchiectasis10.3CFTR, SCT
20glucosidase acid-1,4-alpha deficiency10.3SCT, SST
21bile duct cystadenocarcinoma10.3CCK, SCT
22ferguson-smith tumor10.3SCT, SST
23cervical non-keratinizing squamous cell carcinoma10.3CCK, SCT
24primrose syndrome10.2CCK, SCT
25pelvic varices10.2CCK, SST
26aggressive systemic mastocytosis10.2CCK, SCT
27motility-related diarrhea10.2CFTR, SST
28ring staphyloma10.2CCK, SST
29richter's syndrome10.1SCT, SST
30renal cell carcinoma 410.1CCK, SST
31intracortical osteogenic sarcoma10.1CCK, SST
32partial of retinal vein occlusion10.1CCK, SST
33viral gastritis10.1CCK, SST
34dermatomyositis10.0CCK, SST
35hypoparathyroidism10.0
36diarrhea10.0
37mucopolysaccharidoses10.0CCK, SST
38immunodeficiency, common variable, 510.0SCT, SST
39fecal incontinence10.0CCK, CELA1, SCT
40cystic fibrosis10.0
41vulvar melanoma10.0CCK, SST
42intraocular lymphoma9.9SCT, SST
43pancreatic cystadenocarcinoma9.9CCK, SCT, SST
44peripheral epithelioid sarcoma9.9CCK, SCT, SST
45duodenitis9.9
46inflamed seborrheic keratosis9.9APOC2, MTTP
47endocrine gland cancer9.9CCK, SST
48exocrine pancreatic insufficiency9.8
49zollinger-ellison syndrome9.8
50lymphoma9.8

Graphical network of the top 20 diseases related to Steatorrhea:



Diseases related to steatorrhea

Symptoms & Phenotypes for Steatorrhea

About this section

MGI Mouse Phenotypes related to Steatorrhea according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053766.5APOC2, CCK, CFTR, MTTP, PNLIP, SLC10A2

Drugs & Therapeutics for Steatorrhea

About this section

Drugs for Steatorrhea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PancrelipaseapprovedPhase 4, Phase 3, Phase 2, Phase 193553608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
2pancreatinPhase 4, Phase 3, Phase 2, Phase 1935
3Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 18109
4
Omeprazoleapproved, investigational, vet_approvedPhase 333773590-58-64594
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(S)-(-)-Omeprazole
(S)-Omeprazole
119141-89-8
131959-78-9
172964-80-6
2,3,5-Trimethylpyridine/Omeprazole
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Aulcer
Axagon
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CPD000058847
Ceprandal
D00455
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Esomeprazole
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
IDI1_032523
Indurgan
Inhibitron
Inhipump
LS-7629
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Mepral
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
Mopral
Morecon
NCGC00016925-01
 
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMP
OMZ
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole (JAN/USP/INN)
Omeprazole Pellets
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Prazentol
Prazidec
Prazolit
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
TL8005099
Tedec Ulceral
UNII-KG60484QX9
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
omeprazole
5
Proton pump inhibitorsPhase 31080
Synonyms:
 
PPIs
6AntacidsPhase 31767
7Anti-Ulcer AgentsPhase 31767
8Pharmaceutical SolutionsPhase 2, Phase 37793
9
Menadioneapproved, nutraceuticalPhase 123058-27-54055
Synonyms:
03AAE1E9-B215-45AF-976C-91E61894A467
1,4-Naphthalenedione, 2-methyl-, radical ion(1-)
2-Methyl-1,4-Naphthalenedione
2-Methyl-1,4-naftochinon
2-Methyl-1,4-naftochinon [Czech]
2-Methyl-1,4-naphthalendione
2-Methyl-1,4-naphthalenedione
2-Methyl-1,4-naphthochinon
2-Methyl-1,4-naphthochinon [German]
2-Methyl-1,4-naphthodione
2-Methyl-1,4-naphthoquinone
2-Methylnaphthoquinone
2-methyl-1,4-naphthoquinone, 5
2-methylnaphthalene-1,4-dione
3-Methyl-1,4-naphthoquinone
34524-96-4
47775_SUPELCO
58-27-5
72060-21-0
AC1L1HBA
AC1Q2HB3
AI3-14700
AKOS004910447
ARONIS24154
Aquakay
Aquinone
BB_NC-2319
BIDD:ER0556
BPBio1_000592
BSPBio_000538
Bio1_000471
Bio1_000960
Bio1_001449
C05377
C11H8O2
CAS-58-27-5
CCRIS 6672
CHEBI:28869
CHEMBL590
CID4055
CPD-3766
D02335
DB00170
DivK1c_000080
DivK1c_006287
EINECS 200-372-6
HMS1569K20
HMS1921P06
HMS2092F12
HMS500D22
HSDB 3354
Hemodal
I14-2821
IDI1_000080
InChI=1/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H
Juva-K
K-Thrombyl
K-Vitan
KBio1_000080
KBio1_001231
KBio2_001708
KBio2_002527
KBio2_004276
KBio2_005095
KBio2_006844
KBio2_007663
KBio3_003005
KBioGR_000984
KBioGR_002527
KBioSS_001708
KBioSS_002535
Kaergona
Kanone
Kappaxan
Kappaxan (VAN)
Kappaxin
Kappaxin (TN)
Karcon
Kareon
Kativ-G
Kayklot
Kaykot
 
Kaynone
Kayquinone
Kipca
Kipca, oil soluble
Kipca-Oil Soluble
Klottone
Koaxin
Kolklot
LS-95653
LS-95654
M0373
M5625_SIGMA
M9429_SIGMA
MLS000069420
MLS001148443
MNQ
Memodol
Menadion
Menadione
Menadione (K3)
Menadione (USP)
Menadione [USAN:BAN]
Menadione semiquinone
Menadionum
Menaphthene
Menaphthon
Menaphthone
Menaphtone
Menaquinone
Menaquinone 0
Menaquinone O
Methyl-1,4-naphthalenedione
Methyl-1,4-naphthoquinone
Methylnaphthoquinone
Mitenon
Mitenone
MolPort-001-766-699
NCGC00016258-01
NCGC00094978-01
NCGC00094978-02
NCI60_003945
NCIMech_000105
NINDS_000080
NSC 4170
NSC4170
Panosine
Prestwick0_000459
Prestwick1_000459
Prestwick2_000459
Prestwick3_000459
Prestwick_313
Prokayvit
QTL1_000056
S1949_Selleck
SMR000059102
SMR000653532
SPBio_001267
SPBio_002477
SPECTRUM1502254
SpecPlus_000191
Spectrum2_001194
Spectrum4_000722
Spectrum5_001764
Spectrum_001228
Synkay
Thyloquinone
UNII-723JX6CXY5
Usaf ek-5185
VK3
Vicasol
Vitamin K 3
Vitamin K0
Vitamin K2
Vitamin K2(0)
Vitamin K3
Vitamin K3 : 2-Methyl-1,4-naphthoquinone
Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene
Vitamin-?K3
WLN: L66 BV EVJ C1
ZINC00001677
cMAP_000077
menadione
nchembio.109-comp5
10
Phytonadioneapproved, NutraceuticalPhase 123084-80-04812, 5284607
Synonyms:
.alpha.-Phylloquinone
1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)-, radical ion(1-)
10485-69-5
11104-38-4
15973-57-6
2', 3'-trans-Vitamin K1
2',3'-trans-Vitamin K1
2-(3,7,11,15-Tetramethylhexadec-2-enyl)-3-methylnaphthalene-1,4-dione
2-METHYL-3-PHYTYL-14-NAPHTHOQUINONE
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione
2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone
2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone
2-Methyl-3-phythyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthochinon [German]
2-Methyl-3-phytyl-1,4-naphthoquinone
2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione
2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
27696-10-2
3-Phytylmenadione
50926-17-5
84-80-0
AC1NQX34
AC1Q6B3J
AR-1E3503
Antihemorrhagic vitamin
Aqua mephyton
Aqua-Mephytin
Aquamephyton
C02059
C31H46O2
CID5280483
Combinal K1
D00148
DB01022
EINECS 201-564-2
EINECS 234-330-3
EINECS 279-833-9
Fitomenadiona
Fitomenadiona [INN-Spanish]
Fitomenadione
Fitomenadione [DCIT]
HSDB 3162
K-Ject
Kativ N
Kephton
 
Kinadion
Konakion
LS-94617
LT00452032
MLS001332659
MLS001332660
Mephyton
Mephyton (TN)
MolPort-001-785-978
Mono-Kay
Monodion
NCGC00159423-02
NSC 270681
NSC270681
P0642
Phyllochinon
Phyllochinon [German]
Phyllochinonum
Phylloquinone
Phylloquinone (8CI)
Phythyl-menadion
Phythyl-menadion (GERMAN)
Phytomenadione
Phytomenadione (INN)
Phytomenadionum
Phytomenadionum [INN-Latin]
Phytonadione
Phytonadione (JP15/USP)
Phytonadione [USAN:JAN]
Phytonadionum
Phytylmenadione
SMR000059144
ST075162
Synthex P
UNII-A034SE7857
VITAMIN K
VITAMIN K1
Vitamin K
Vitamin K 1
Vitamin K1
Vitamin K1 (TN)
Vitamin K1 (VAN)
Vitamin K1 (generic)
Vitamin K1(20)
alpha-Phylloquinone
phyllohydroquinone
phytonadione
trans-Phylloquinone
α-phylloquinone
11Trace ElementsPhase 15802
12VitaminsPhase 15095
13MicronutrientsPhase 15802
14HemostaticsPhase 11359
15Antifibrinolytic AgentsPhase 1459
16CoagulantsPhase 11428
17MenaquinoneNutraceuticalPhase 1230
18Vitamin KNutraceuticalPhase 1231
19naphthoquinoneNutraceuticalPhase 1230
20
Nicotineapproved105054-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-(−)-nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(−)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-(N-methylpyrollidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L(−)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
21
Teriparatideapproved, investigational13552232-67-416133850
Synonyms:
52232-67-4
D06078
Forteo
Forteo (TN)
 
TERIPARATIDE
Teriparatide (USAN/INN)
Teriparatide (genetical recombination)
Teriparatide (genetical recombination) (JAN)
Teriparatide recombinant human
22glucocorticoids4920
23vitamin d1653
24Antibodies6045
25Immunoglobulins6045
26Bone Density Conservation Agents3266
27Calcium, Dietary5525
28Bile Acids and Salts102

Interventional clinical trials:

(show all 26)
idNameStatusNCT IDPhase
1Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyCompletedNCT01327703Phase 4
2Malabsorption Blood Test:Toward a Novel Approach to Quantify SteatorrheaCompletedNCT00572975Phase 4
3Enzyme Suppletion in Exocrine Pancreatic DysfunctionCompletedNCT01430234Phase 4
4Pancreatic Enzyme Suppletion in Pancreatic CancerWithdrawnNCT01401387Phase 4
5Safety and Efficacy Study of Viokase® 16 for the Correction of SteatorrheaCompletedNCT00559364Phase 3
6Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)CompletedNCT00880100Phase 3
7Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic FibrosisCompletedNCT00432861Phase 3
8Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)CompletedNCT00408317Phase 3
9A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic InsufficiencyCompletedNCT00662675Phase 3
10Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)CompletedNCT00513682Phase 3
11Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantationActive, not recruitingNCT01967888Phase 2, Phase 3
12Creon in HIV Patients With SteatorrheaTerminatedNCT00623025Phase 3
13Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two DrugsWithdrawnNCT01228643Phase 3
14An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat MalabsorptionCompletedNCT00217204Phase 2
15Tolerance and Digestibility of a New Formula in Healthy InfantsCompletedNCT01184378Phase 2
16An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)CompletedNCT00559052Phase 2
17A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)CompletedNCT00676702Phase 1
18Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic FibrosisCompletedNCT00006063
19Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
20Horton & Maizy Pilot Study for Resistant to StarchCompletedNCT01338571
21Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute PancreatitisCompletedNCT01527084
22Effect of Potato Fiber on Appetite and Fecal Fat ExcretionRecruitingNCT02957318
23Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.RecruitingNCT02242123
24Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium DisordersRecruitingNCT02252679
25Comparison of Feasibility Between Internal and External Pancreatic Drainage in PancreaticoduodenectomyActive, not recruitingNCT01023594
26The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"Active, not recruitingNCT02121626

Search NIH Clinical Center for Steatorrhea


Cochrane evidence based reviews: steatorrhea

Genetic Tests for Steatorrhea

About this section

Genetic tests related to Steatorrhea:

id Genetic test Affiliating Genes
1 Steatorrhea27

Anatomical Context for Steatorrhea

About this section

MalaCards organs/tissues related to Steatorrhea:

36
Testes, Bone, Pancreatic islet, Pancreas, Colon, Liver, Small intestine

Publications for Steatorrhea

About this section

Articles related to Steatorrhea:

(show top 50)    (show all 314)
idTitleAuthorsYear
1
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass. (28089681)
2017
2
Risk Factors for Steatorrhea in Chronic Pancreatitis: A Cohort of 2,153 Patients. (26877248)
2016
3
Dietary green-plant thylakoids decrease gastric emptying and gut transit, promote changes in the gut microbial flora, but does not cause steatorrhea. (27777602)
2016
4
50 years ago in the journal of pediatrics: disaccharidase deficiencies with steatorrhea. (24359902)
2014
5
Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. (23395568)
2013
6
Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate. (23499748)
2013
7
Education and imaging. Gastrointestinal: "floating oil droplets in the colonic fluid": colonoscopic findings in a patient with pancreatic exocrine insufficiency and steatorrhea. (21564288)
2011
8
Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? (21377551)
2011
9
Pancreatic lipomatosis with massive steatorrhea. (22081194)
2011
10
Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea. (20146370)
2010
11
Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea. (19238028)
2009
12
Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis. (19034041)
2009
13
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. (16954337)
2007
14
Spontaneous exocrine pancreas hypoplasia in specific pathogen-free C3HeB/FeJ and 101/H mouse pups causes steatorrhea and runting. (17536623)
2007
15
The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. (16868481)
2006
16
Unresponsive or non-compliant steatorrhea in cystic fibrosis? (16765107)
2006
17
An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. (16863712)
2006
18
Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes? (16505538)
2006
19
The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. (12728924)
2003
20
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. (14560984)
2003
21
Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea. (12394373)
2002
22
Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic steatorrhea? (11374718)
2001
23
Massive steatorrhea in a child due to isolated pancreatic hypoplasia. (11721073)
2001
24
Association between steatorrhea, growth, and immunologic status in children with perinatally acquired HIV infection. (11177089)
2001
25
A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. (10950038)
2000
26
Positive results on tests for steatorrhea in persons consuming olestra potato chips. (10681282)
2000
27
Study on pancreatic insufficiency (chronic pancreatitis) and steatorrhea in Japanese patients with low fat intake. (10026440)
1999
28
Fecal weight determination can unfortunately not replace unpopular and costly fecal fat estimation in the diagnosis of steatorrhea. (10211425)
1999
29
Steatorrhea and weight loss in a 72-year-old man: primary biliary cirrhosis? Celiac disease? Bacterial overgrowth? What else? (9820402)
1998
30
Esophageal impairment in adult celiac disease with steatorrhea. (9707045)
1998
31
Prevalence and significance of steatorrhea in patients with active Graves' disease. (9672342)
1998
32
Steatorrhea cannot be excluded where there is a fecal weight below 0.200 kg per day and a high fecal consistency. (9890341)
1998
33
Determination of fecal fat concentration by near infrared spectrometry for the screening of pancreatic steatorrhea. (9520087)
1998
34
Bone mineral density in patients with pancreatic insufficiency and steatorrhea. (9149203)
1997
35
Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? (9178698)
1997
36
Can pancreatic steatorrhea be diagnosed without chemical analysis? (9387033)
1997
37
Pancreatic steatorrhea, malabsorption, and nutrition biochemistry: a comparison of Japanese, European, and American patients with chronic pancreatitis. (9163777)
1997
38
Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea. (9399770)
1997
39
Steatorrhea: a common manifestation in patients with HIV/AIDS. (8878143)
1996
40
Evaluation of steatorrhea during acute infectious enteritis. (8890096)
1996
41
Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. (7883852)
1995
42
Steatorrhea in Japanese patients with chronic pancreatitis. (7719419)
1995
43
Fat-soluble vitamin concentration in chronic alcohol-induced pancreatitis. Relationship with steatorrhea. (8174441)
1994
44
Octreotide decreases biliary and pancreatic exocrine function, and induces steatorrhea in healthy subjects. (7827373)
1994
45
New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea. (8113582)
1994
46
Steatocrit: a reliable semiquantitative method for detection of steatorrhea. (7806830)
1994
47
Fecal fat concentration in the screening of steatorrhea. (1289179)
1992
48
Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon. (1587199)
1992
49
Can diarrhea cause secondary steatorrhea? (1587441)
1992
50
Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. (1624649)
1992

Variations for Steatorrhea

About this section

Expression for genes affiliated with Steatorrhea

About this section
Search GEO for disease gene expression data for Steatorrhea.

Pathways for genes affiliated with Steatorrhea

About this section

GO Terms for genes affiliated with Steatorrhea

About this section

Cellular components related to Steatorrhea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055769.2APOC2, CCK, PNLIP, SCT, SST
2extracellular spaceGO:00056158.4APOC2, CCK, CELA1, SCT, SST

Biological processes related to Steatorrhea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cholesterol homeostasisGO:00426329.9APOC2, MTTP
2lipoprotein metabolic processGO:00421579.8APOC2, MTTP
3retinoid metabolic processGO:00015239.7APOC2, PNLIP

Molecular functions related to Steatorrhea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hormone activityGO:00051799.3CCK, SCT, SST

Sources for Steatorrhea

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet